Drug Shortage Report for DEPO-PROVERA

Last updated on 2021-07-22 History
Report ID 131486
Drug Identification Number 00585092
Brand name DEPO-PROVERA STERILE AQUEOUS SUSPENSION 150 MG/ML
Common or Proper name DEPO-PROVERA
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) MEDROXYPROGESTERONE ACETATE
Strength(s) 150MG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1 x 1ML
ATC code G03AC
ATC description HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-07-23
Actual start date 2021-07-21
Estimated end date 2022-06-01
Actual end date
Shortage status Actual shortage
Updated date 2021-07-22
Company comments Other presentation available: US-labelled pre-filled syringes We do not anticipate a gap in supply of DEPO-PROVERA on the Canadian market in 2021-2022.
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v20 2021-07-22 English Compare
v19 2021-07-21 French Compare
v18 2021-07-21 English Compare
v17 2021-07-20 French Compare
v16 2021-07-20 English Compare
v15 2021-07-20 English Compare
v14 2021-07-14 French Compare
v13 2021-07-14 English Compare
v12 2021-05-21 French Compare
v11 2021-05-21 English Compare
v10 2021-04-09 French Compare
v9 2021-04-09 English Compare
v8 2021-04-09 English Compare
v7 2021-01-27 French Compare
v6 2021-01-27 English Compare
v5 2021-01-26 French Compare
v4 2021-01-26 English Compare
v3 2021-01-13 English Compare
v2 2021-01-12 French Compare
v1 2021-01-12 English Compare